| Developers: | Singular Wings Medical |
| Date of the premiere of the system: | October 2024 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2024: Product Announcement
In mid-October 2024, Singular Wings Medical announced the development of a compact device that allows continuous monitoring of glucose levels according to electrocardiogram (ECG) data. The novelty is expected to help improve the quality of life of people with diabetes.
Continuous glucose monitoring systems are more efficient than conventional glucose meters. With the help of such a diagnosis, it is possible to respond in a timely manner to changes in blood sugar levels, preventing deterioration in well-being and the development of complications associated with hypoglycemia or hyperglycemia. However, existing solutions for continuous glucose monitoring are invasive - they use microneedles. In addition, such devices have a limited service life. The technology proposed by Singular Wings Medical circumvents these limitations.
The researchers say that low blood sugar (hypoglycemia) and high blood sugar (hyperglycemia) affect the electrical characteristics of the heart, causing certain changes that can be seen on the ECG. To assess glucose levels according to ECG data, special algorithms based on artificial intelligence are used. Only at the training stage of the corresponding AI model was it possible to demonstrate accuracy at the level of 80%, and in the future this indicator will be increased.
The ECG is recorded using Singular Wings' Beatinfo sensor, which integrates with the Beatinfo Health app available Apple Store in and. Google Play The sensor weighing only 15 grams can be used continuously by diabetics. The device transmits data to the mobile application in real time and notifies the user if blood sugar levels are outside the normal range.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |